GlassScriptPhysician profile
Richard S Omsberg
NPI 1366569402
$3,527.68
in general payments reported to CMS, 2019-2025
36 companies · $603 in 2025
The $603 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $675 · 2022: $714 · 2023: $515 · 2024: $1,019 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,137.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $575.13 | 2021-2024 | Xiaflex, Aveed, Edex |
| Abbvie INC. | $398.85 | 2021-2025 | |
| Procept Biorobotics Corporation | $342.51 | 2021-2025 | Aquabeam System, Aquabeam Robotic System |
| Olympus America INC. | $247.72 | 2024-2025 | Itind System |
| Endo USA, INC. | $169.19 | 2024-2025 | Xiaflex, Aveed |
| Boston Scientific Corporation | $155.81 | 2021 | |
| Sumitomo Pharma America, INC. | $154.55 | 2023-2025 | Orgovyx, Gemtesa |
| Astrazeneca Pharmaceuticals LP | $124.71 | 2022 | |
| Axonics, INC. | $116.50 | 2023 | Axonics |
| Teleflex LLC | $114.39 | 2022-2024 | Urolift |
| Urogen Pharma, INC. | $109.12 | 2024-2025 | |
| Acerus Pharmaceuticals Corporation | $103.13 | 2021-2022 | |
| 180 Medical, INC. | $96.84 | 2021-2022 | |
| Clarus Therapeutics INC. | $86.66 | 2021 | |
| Myriad Genetic Laboratories, INC. | $67.94 | 2021-2023 | Myrisk |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $65.20 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $56.91 | 2024-2025 | |
| Janssen Biotech, INC. | $55.10 | 2022-2025 | Erleada |
| Halozyme INC | $52.80 | 2023 | |
| Urovant Sciences INC | $51.44 | 2022 | |
| Inspire Medical Systems, INC. | $48.38 | 2023-2024 | Inspire |
| Tolmar, INC. | $45.21 | 2023 | |
| Pfizer INC. | $43.07 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $28.94 | 2024 | Welireg |
| Coloplast Corp | $27.64 | 2021 | |
| Accord Healthcare, INC. | $24.17 | 2024 | |
| Progenics Pharmaceuticals, INC. | $20.19 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.74 | 2022 | |
| Verity Pharmaceuticals INC. | $17.83 | 2022 | |
| Dendreon Pharmaceuticals LLC | $17.53 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.49 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.40 | 2022 | |
| Millicent US INC | $15.56 | 2024 | Intrarosa |
| Ferring Pharmaceuticals INC. | $15.32 | 2024 | Adstiladrin |
| Blue Earth Diagnostics | $14.05 | 2021 | |
| Civco Medical Instruments | $13.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Omsberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.